menu
    • menu

    Company profile for Windlas Biotech Limited

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    In pharmaceutical vertical, the family has two companies – Windlas Biotech Limited (WBL) and Windlas Healthcare Private Limited (WHC). WBL was founded in year 2000 with and provides contract manufacturing services for the Indian pharma market, employing over 400 staff and workers, and has a revenue of about Rs. 80 crores in the last fiscal (FY ‘08-’09). WBL also promotes its own branded generic products in India with a s...
    In pharmaceutical vertical, the family has two companies – Windlas Biotech Limited (WBL) and Windlas Healthcare Private Limited (WHC). WBL was founded in year 2000 with and provides contract manufacturing services for the Indian pharma market, employing over 400 staff and workers, and has a revenue of about Rs. 80 crores in the last fiscal (FY ‘08-’09). WBL also promotes its own branded generic products in India with a small sales team of 180 people. WHC is a brand new oral solid dosage (tablets and capsules) formulations facility commissioned in 2009. This plant has been designed to be compliant with the US FDA and EU cGMP standards.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Windlas Biotech Limitedindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Windlas Healthcare Private Limited 112, Radisson Suites, Bestech Chambers, Sus...
    Telephone
    Telephone
    91 124 4641900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://windlas.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Windlas Biotech Net Profit Rises 3.18% In Q3
    Windlas Biotech Net Profit Rises 3.18% In Q3

    11 Feb 2025

    // BUSINESS STD

    https://www.business-standard.com/markets/capital-market-news/windlas-biotech-consolidated-net-profit-rises-3-18-in-the-december-2024-quarter-125021101459_1.html

    BUSINESS STD
    11 Feb 2025
    Share Share
    FDA letter blasts Windlas for 'cartloads' of shredded documents
    FDA letter blasts Windlas for 'cartloads' of shredded documents

    18 Mar 2020

    // Kyle Blankenship FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/shredded-documents-and-trick-cameras-fda-knocks-indian-drugmaker-windlas-warning

    Kyle Blankenship FIERCE PHARMA
    18 Mar 2020
    Share Share
    Windlas Healthcare Private Limited Receives FDA Warning Letter
    Windlas Healthcare Private Limited Receives FDA Warning Letter

    18 Mar 2020

    // FDA

    https://www.pharmacompass.com/pdf/news/windlas-healthcare-private-limited-receives-fda-warning-letter-1584513747.pdf

    FDA
    18 Mar 2020
    Share Share
    Sunstar Guangzhou Ltd on FDA Import Alert List
    Sunstar Guangzhou Ltd on FDA Import Alert List

    21 Jan 2020

    // FDA

    https://www.accessdata.fda.gov/cms_ia/importalert_189.html

    FDA
    21 Jan 2020
    Share Share
    Tecfidera (dimethyl fumarate) : Biogen International v. Windlas Healthcare
    Tecfidera (dimethyl fumarate) : Biogen International v. Windlas Healthcare

    31 Aug 2018

    // PATENT LITIGATION

    https://www.pharmacompass.com/pdf/news/tecfidera-dimethyl-fumarate-biogen-international-v-windlas-healthcare-1536060416.pdf

    PATENT LITIGATION
    31 Aug 2018
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search